August 11th 2025
NRx Pharmaceuticals secures FDA Fast Track designation for NRX-100, a preservation-free formulation of intravenous ketamine for suicidal ideation in depression.
Rescuing an Essential Component of Psychiatry: Psychotherapy Training in Psychiatric Education
February 10th 2020A diminished interest in psychotherapeutic interventions runs the risk of missing patients' emotional, social, and practical needs (including medication-modifiable symptoms) and, thus, less clinically responsible care.
Read More
Integrating Psychotherapy and Psychopharmacology in the Treatment of Major Depressive Disorder
January 30th 2020Although multiple interventions exist for major depressive disorder (MDD), only partial response is achieved in many patients and recurrence is common. Combining medication and psychotherapy may enable more effective treatment of MDD.
Read More
Year in Review: 2019 Special Reports in Psychiatry
December 2nd 2019As varied as the field of psychiatry itself, our Special Report collections covered issues such as eating disorders, traumatic brain injury, practice management, schizophrenia and depression, complex medical comorbidities, and more. Here's a sampling.
Read More
Multidisciplinary Team Explores Link Between Asthma and Depression
August 16th 2019In a first-of-its-kind study, researchers from the Icahn School of Medicine at Mount Sinai, Montefiore Health System, and Albert Einstein College of Medicine are working together to examine the link between depression and asthma in older adults.
Read More